Pediatric drug safety lags behind due to challenges in running clinical trials that include children. TLab member, Nicholas Giangreco led the development of novel methods to improve the drug safety landscape in children as part of his dissertation work. His final paper, published in the August 12th issue of Med, is now available and presents a comprehensive look at the unique pediatric drug safety signals he discovered.

Med, which is Cell Press’s flagship medical journal, has featured Nick’s work on the cover of the latest issue of their journal. Find out more about our study and check out all the articles in the issue here: https://www.cell.com/med/current